Around 88% of primary care providers managing patients with uncontrolled asthma reported being unfamiliar or only somewhat familiar with biologic therapy, according to survey findings.These data were ...
A chemistry professor who researches ice and snow says the snow is real. The black marks are from the lighter’s soot, and the ...
Bionano Genomics (NASDAQ: BNGO) participated in the Association for Molecular Pathology (AMP) Annual Meeting, held November 11-15, 2025 in Boston, MA. Key presentations at the conference highlighted ...
21m
CMS (867/8A8): NDA of Innovative Drug Y-3 for Injection for Acute Ischemic Stroke Accepted in China
With well-defined targets and clear mechanism of action, Y-3 for Injection is able to exert multiple therapeutic effects. As the world’s first brain cytoprotectant developed based on the important ...
TuHURA Biosciences, Inc. (NASDAQ:HURA) ("TuHURA"), a Phase 3 immune-oncology company developing novel technologies to ...
OpenBench, Inc., a biotechnology company pioneering success-driven molecular discovery partnerships, and Brii Biosciences Limited, a biotechnology company developing therapies to improve patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results